SDS

Safety Data Sheet – LeakBarrier BG700 Page 7 of 7
SECTION 15 REGULATORY INFORMATION
INTERNATIONAL REGULATIONS
These products are not considered articles per international product regulations and as such, these products do not require
registration or notification on the various country-specific inventories
.
U. S. FEDERAL REGULATIONS
TSCA
This product contains some components that are listed on the TSCA 8(b) inventory
CERCLA
None
SARA
Section 302
None of the product components are listed under this section
Section 311/312
Acute Health: Yes; Chronic Health: Yes
Section 313
None of the product components are listed under this section
STATE REGULATIONS
Component Analysis State:
The following components appear on one or more of the
following state hazardous substances lists.
CHEMICAL NAME COMMON NAME CAS NUMBER CA MA MN NJ PA RI
Asphalt Asphalt Flux 8052-42-4 Yes Yes Yes Yes Yes Yes
Calcium Carbonate Limestone 1317-65-3 No Yes Yes No Yes Yes
Note:
TSCA Toxic Substances Control Act
CERCLA Comprehensive Environmental Response Compensation and Liabilities Act
SARA Superfund Amendments and Reauthorization Act of 1986 (SARA) Title III
Section 302 Extremely Dangerous Hazardous Substances
Section 311/312 Immediate health; Delayed health; Fire hazard
Section 313 Reportable Ingredients
SECTION 16 OTHER INFORMATION
DATE OF PREPARATION
November 11, 2019
DATE OF LAST REVISION
August 26, 2019
CHANGES SINCE LAST-
REVISION
Removal of California Prop 65 language in Section 15
PREPARED BY
Tarco
DISCLAIMER
The information and recommendations contained herein are to the best of the manufacturer’s
knowledge and belief, and are presented in good faith and believed to be accurate as of the
effective date given. However, no warranty, expressed or implied, is given. It is the buyer’s
responsibility to ensure that its activities comply with Federal, State, and Local laws. The
supplier shall not be liable for any loss or damage arising out of the use thereof. The
information and recommendations are offered for the user’s consideration and examination,
and it is the user’s responsibility to ensure the suitability and completeness of such information
for a particular use. No information or recommendation shall be deemed to be a
recommendation to use any product in conflict with any existing patent rights.